Validation and analysis of key factors of Banxia Xiexin decoction against gastric cancer

Figure 8 Protein expression of phosphatidylinositol 3-kinase-AKT signaling pathway in tumor tissues of animals in each group A: Relative expression of AKT serine/threonine kinase 1 protein in tumor tissues of animals in each group; B: Relative expression of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha protein in tumor tissues of animals in each group; C: Relative expression of phosphoinositide-3-kinase regulatory subunit 1 protein in tumor tissues of animals in each group; D: AKT serine/threonine kinase 1, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, and phosphoinositide-3-kinase regulatory subunit 1 protein bands. Compared with the model group, ^bP < 0.01. BXD-L: Banxia Xiexin decoction low dose; BXD-M: Banxia Xiexin decoction medium dose; BXD-H: Banxia Xiexin decoction high dose; PIK3R1: Phosphoinositide-3-kinase regulatory subunit 1; PIK3CA: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; AKT1: AKT serine/threonine kinase 1; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.